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The reaction of aryl isoselenocyanates 8 with methyl 3-amino-4-chloro-1-ethylpyrrolo[3,2-
c]quinoline-2-carboxylate (6) in boiling pyridine leads to tetracyclic selenaheterocycles of type 9 
in high yield (Scheme 3). A reaction mechanism via an intermediate selenourea derivative A and 
cyclization via nucleophilic substitution of Cl by Se is proposed (Schemes 3 and 5). The reaction 
of 6 with (4-bromophenyl) isothiocyanate yields the analogous thiaheterocycle 12 (Scheme 4). 
The molecular structures of 9c and 12 have been established by X-ray crystallography. 
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1. Introduction 
The current interest in the chemistry of Se-containing compounds is well documented (cf. 
[1-4] and refs. cit. in [5]). A series of recent papers deals with biological activities and the 
pharmaceutical potential of Se-compounds (e.g. [6-10]). For example, some organo-selenium 
compounds are active as insecticides and microbicides [11], as prooxidants [12], and 
antimycobacterial agents [13]. Recently, the research group of Koketsu published some novel 
syntheses of selenaheterocycles [13-15]. 
Within our own research project, we have used aroyl isoselenocyanates 1a and N-
phenylbenzimidoyl isoselenocyanates 1b as conveniently accessible, cheap and safe Se reagents 
for the preparation of 1,2,3-selenadiazole 2 [16] and 1,3-selenazole derivatives 3 [17], 
respectively (Scheme 1). In the case of 1c, treatment with amines led to 6H-5,1,3-
benzoselenadiazocines 4 [18], whereas the base-catalyzed cyclization of 1d yielded bis(2,4-
diarylimidazol-5-yl) diselenides 5 [5]. 
 
Scheme 1 
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Although the chemistry of Se-containing compounds is often similar to that of the 
corresponding S analogues, some significant differences are also known, and because of the 
toxicity and instability of many Se compounds, the synthesis of Se heterocycles is much less 
developed. Therefore, new approaches by using more stable, less toxic, and easily accessible Se 
reagents are of high interest. For this reason, we have investigated reactions of aryl 
isoselenocyanates as starting materials for the preparation of selenaheterocycles. 
In the present paper, we report the results of the reaction of aryl isoselenocyanates with 
methyl 3-amino-4-chloro-1-ethylpyrrolo[3,2-c]quinoline-2-carboxylate (6). The latter was used 
recently by Mekheimer to prepare fused tri- and tetracyclic quinoline derivatives [19]. Among 
several transformations, he described the reaction with phenyl and allyl isothiocyanate, which 
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gave – according to his interpretation – the corresponding 5-substituted methyl 1-ethyl-4-thioxo-
3(4H)-1,3,5,6-tetraaza-aceanthrylene-2-carboxylate 7 (Scheme 2). 
 
Scheme 2 
 
 
 
2. Results and Discussion 
To a solution of 6 in anhydrous pyridine, ca. 1.1 equiv. of the freshly prepared aryl 
isoselenocyanate 8 was added, and the mixture was heated under reflux for 5 h. After evaporation 
of the solvent, trituration of the residue with MeOH, and recrystallization, the corresponding 
yellowish crystalline product 9 was obtained (Scheme 3). According to the CI-MS and elemental 
analyses, these products were formed by addition of 6 and 8 and elimination of HCl. The IR 
spectra (KBr) showed absorptions at 3274-3244 and 1714-1692 cm-1 for NH and the ester C=O 
group, and the corresponding signals appeared at 10.40-10.06 and 162.8-161.4 ppm in the 1H- 
and 13C-NMR spectra. Other characteristic signals were present for the EtN and the MeO groups 
as well as for the C-atoms of the polycyclic skeleton in the aromatic region. 
 
Scheme 3 
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As we expected that the formed products were Se analogues of 7 (Scheme 2), we tried to 
form the corresponding diselenides by oxidation (cf. [5]), but all attempts failed. Furthermore, 
methylation of 9b by treatment with NaH and MeI gave a product 10, which was not a 
methylseleno derivative. The Me absorption at 3.63 ppm (1H-NMR) clearly shows that 10 is an 
N-methyl derivative. 
 
In the case of the 4-bromophenyl derivative 9c, single crystals were obtained from DMF, 
and the 1H-5-selena-1,3,6-triazaaceanthrylene structure of the molecule was established by X-ray 
crystallography (Fig. 1). 
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Fig. 1. ORTEP-Plot [20] of the molecular structure of 9c (arbitrary numbering of atoms; 
50% probability ellipsoids) 
 
The tetracyclic ring system of 9c is almost planar, and the ester group is coplanar with the 
ring system. The 4-bromophenyl ring at N(2) is twisted out of the heterocyclic plane  by ca. 23° 
(torsion angles C(2)-N(2)-C(17)-C(18) –158.5(3)°, C(2)-N(2)-C(17)-C(22) 23.9(4)°). The Et 
group at N(6) is almost orthogonal to the ring skeleton (C(5)-N(6)-C(25)-C(26) –96.5(3)°). The 
NH group forms an intermolecular H-bond with the O-atom of the ester C=O group of a 
neighboring molecule, thereby linking the molecules into infinite chains which run in the [101] 
direction and have a graph set motif [21] of C(8). 
 
A reaction mechanism for the formation of 9 is proposed in Scheme 3. Nucleophilic 
addition of the NH2 group of 6 to the isoselenocyanate 8 leads to the selenourea derivative A. The 
new selenaheterocycle is formed by nucleophilic substitution of Cl of the β-chloroquinoline 
residue via attack of the Se atom, where B is an intermediate. As the reaction is carried out in 
pyridine, a base-catalysis of the ring closure is likely. 
 
8 
 
Because of the discrepancy between the reported reaction of 6 with isothiocyanates 
(Scheme 2) and the reaction with isoselenocyanates (Scheme 3), we also carried out a reaction 
with an aryl isothiocyanate. Treatment of 6 with (4-bromophenyl) isothiocyanate in pyridine at 
room temperature gave 12 in 64% yield (Scheme 4). According to the 1H- and 13C-NMR spectra 
in (D7)DMF, there are two tautomeric forms 12 and 12' present in a ratio of ca. 2:1. Crystals 
suitable for X-ray crystallography were obtained from DMSO (Fig. 2). The molecular structure 
of 12 is very similar to that of the corresponding Se analogue 9c. The main difference is that the 
4-bromophenyl ring at N(2) is almost coplanar with the heterocyclic ring system (torsion angles 
C(2)-N(2)-C(17)-C(18) –177.0(2)°, C(2)-N(2)-C(17)-C(22) 2.8(3)°). The asymmetric unit 
contains one molecule of 12 plus one molecule of DMSO. The NH group forms an 
intermolecular H-bond with the O-atom of a neighboring DMSO molecule. This interaction does 
not form an extended network and has a graph set motif of D.  
 
 
 
Fig. 2. ORTEP-Plot [20] of the molecular structure of 12 (arbitrary numbering of atoms; 
50% probability ellipsoids) 
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In conclusion, we have shown that the reactions of 6 with aryl isoseleno- and 
isothiocyanates proceed in a consistent manner leading to the fused tetracyclic ring systems 9 and 
12, respectively. In both cases, the ring closure of the intermediate urea derivative of type A takes 
place by the nucleophilic attack of the Se and S atom (Scheme 5). The alternative cyclization via 
the N-atom of the urea derivatives, which was postulated to lead to the heterocycles of type 7 
[19], was not observed. Therefore, the structures proposed in [19] have to be revised. 
 
Scheme 5 
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this work by the Swiss National Science Foundation and F. Hoffmann-La Roche AG, Basel, is 
gratefully acknowledged. 
 
Experimental Part 
 
1. General. See [16]. 
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2. Starting materials. The aryl isoselenocyanates 8a – d were prepared according to the 
protocol described in [22]. To a stirred soln. of the corresponding N-arylformamide (40 mmol) in 
abs. toluene (100 ml) in an ice bath were added Et3N (16.2 g, 160 mmol) and Se black powder. 
Then, phosgene (30 g of a 20% soln. in toluene, 60 mmol) was added slowly within 30 min. An 
exothermic reaction took place. After complete addition, the suspension was heated under reflux 
for 8 – 10 h (TLC control). The mixture was filtered and washed with several portions of toluene, 
the filtrate was concentrated and fractionated over SiO2 using hexane as the eluent. Phenyl 
Isoselenocyanate (8a) [22]: 4.84 g (40 mmol) of N-phenylformamide. Yield: 3.24 g (45%). (4-
Chlorophenyl) Isoselenocyanate  (8b) [22]: 6.22 g (40 mmol) of N-(4-chlorophenyl)formamide. 
Yield: 4.77 g (55%). (4-Bromophenyl) Isoselenocyanate (8c): 8.00 g (40 mmol) of N-(4-
bromophenyl)formamide. Yield: 6.05 g (58%). (4-Methoxyphenyl) Isoselenocyanate (8d) [22]: 
6.05 g (40 mmol) of N-(4-methoxyphenyl)formamide. Yield: 3.56 g (42%). N-(4-Chlorophenyl)- 
and N-(4-bromophenyl)formamide were prepared according to [23] by heating the corresponding 
aniline (20 mmol) in 95% formic acid under reflux for 30 min. After workup, the products were 
recrystallized from H2O. N-(4-Methoxyphenyl)formamide was prepared according to [24]. After 
evaporation of the solvent, the residue was dissolved in AcOEt and the soln. was washed with 5% 
aq. NaHCO3 and H2O. The org. layer was dried (MgSO4), the solvent evaporated, and the crude 
product was used without further purification. Methyl 3-Amino-4-chloro-1-ethylpyrrolo[3,2-
c]quinoline-2-carboxylate (6) was synthesized following the protocol in [19]. Cream-colored 
crystals. M.p. 185 – 186° (acetone). IR: 3496m, 3384m, 3068w, 3016w, 2985w, 2956m, 2930w, 
1692s, 1602s, 1573s, 1556m, 1534s, 1507s, 1472m, 1435s, 1409w, 1374s, 1356m, 1330m, 
1298m, 1276s, 1255m, 1240s, 1180s, 1160s, 1102s. 1H-NMR (500 MHz, (D6)DMSO): 8.38 (dd, 
J = 8.4, 0.9, 1 arom. H ); 7.93 (dd, J = 8.2, 1.3, 1 arom. H); 7.73 (td, J = 8.2, 1.3, 1 arom. H); 7.67 
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(td, J = 8.4, 1.4, 1 arom. H); 6.04 (s, NH2); 4.84 (q, J = 7.0, CH2); 3.90 (s, MeO); 1.47 (t, J = 7.0, 
MeCH2). 
13C-NMR ((D6)DMSO): 161.7 (s, CO); 145.1, 144.3, 137.4, 136.4, 116.9, 108.0, 106.8 
(7s, 7 arom. C); 129.0, 128.8, 126.7, 122.6 (4d, 4 arom. CH); 51.1 (q, MeO); 42.0 (t, CH2); 15.2 
(q, MeCH2). CI-MS: 304 (100, [M+1]
+). Anal. calc. for C15H14ClN3O2 (303.74): C 59.31, H 4.65, 
N 13.83; found C 59.15, H 4.63, N 13.84. 
 
3. Preparation of 1H-5-Selena-1,3,6-triazaaceanthrylene-2-carboxylates 9a – d. General 
Procedure. To a soln. of 6 in anhydrous pyridine, the freshly prepared arylisoselenocyanate 8 was 
added under stirring at r.t. The mixture was heated under reflux for 5 h. After cooling, the solvent 
was evaporated i.v. and the remaining oily residue was triturated with MeOH. The resulting solid 
product was collected by filtration and purified by recrystallization from MeOH or 
CH2Cl2/hexane. 
Methyl 1-Ethyl-4-(phenylamino)-1H-5-selena-1,3,6-triazaaceanthrylene-2-carboxylate (9a). 
From 0.5 g (1.64 mmol) of 6 and 0.33 g (1.81 mmol) of 8a: Yield: 0.55 g (75.3%). Yellowish 
crystals. M.p. 256.1 – 257.0° (MeOH). IR: 3244w, 3191w, 3125w, 3047m, 3012m, 2974m, 
2931m, 1714s, 1628s, 1590s, 1569s, 1557s, 1546s, 1496s, 1456m, 1438s, 1371m, 1354m, 1312m, 
1295m, 1269m, 1244m, 1216m, 1199m, 1183m, 1163m, 1140w, 1111s. 1H-NMR (500 MHz, 
(D6)DMSO): 10.20 (s, NH); 8.33 (d, J = 7.6, 1 arom. H); 8.09 (d, J = 8.0, 2 arom. H); 7.91 (dd, J 
= 8.2, 1.2, 1 arom. H); 7.68 (td, J = 8.1, 1.1, 1 arom. H); 7.61 (td, J = 8.3, 1.3, 1 arom. H); 7.39 
(dd, J = 8.4, 7.4, 2 arom. H); 7.08 (t, J = 7.3, 1 arom. H); 4.95 (q, J = 7.0, CH2); 3.99 (s, MeO); 
1.51 (t, J = 7.0, MeCH2). 
13C-NMR ((D6)DMSO): 161.4 (s, CO); 152.4, 147.6, 147.2, 140.4, 
135.4, 131.1 (6s, 7 arom. C); 128.7, 128.6, 128.5, 125.9, 122.9, 122.5, 119.4 (7d, 9 arom. CH); 
117.9, 105.0 (2s, 2 arom. C);  51.5 (q, MeO); 41.9 (t, CH2); 15.4 (q, MeCH2). CI-MS: 451 (100, 
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[M+1]+). Anal. calc. for C22H18N4O2Se (449.36)
2): C 58.80, H 4.04, N 12.47; found: C 56.84, H 
4.25, N 11.95. 
Methyl 4-[(4-Chlorophenyl)amino]-1-ethyl-1H-5-selena-1,3,6-triazaaceanthrylene-2-carboxylate 
(9b). From 0.4 g (1.31 mmol) of 6 and 0.31 g (1.42 mmol) of 8b: Yield: 0.55 g (87.3%). 
Yellowish crystals. M.p. 271.0 – 272.1° (MeOH). IR: 3261w, 3190w, 3102m, 3055m, 2990m, 
2950m, 1694s, 1605s, 1570s, 1549s, 1489s, 1461m, 1435s, 1420w, 1400m, 1373s, 1353m, 1308s, 
1292s, 1263m, 1246m, 1223s, 1196m, 1180m, 1161m, 1135w, 1110s, 1094m. 1H-NMR 
((D7)DMF): 10.62 (s, NH); 8.62 (d, J = 8.2, 1 arom. H); 8.50 (d, J = 8.8, 2 arom. H); 8.18 (d, J = 
8.0, 1 arom. H); 7.95 – 7.82 (m, 2 arom. H); 7.71 (d, J = 8.8, 2 arom. H); 5.26 (q, J = 7.0, CH2); 
4.35 (s, MeO); 1.85 (t, MeCH2, J = 7.0). 
13C-NMR ((D7)DMF): 162.8 (s, CO)
3); 153.0, 148.5, 
140.5, 132.0, 129.8, 129.3, 118.1 (7s, 10 arom. C); 129.1, 127.5, 126.5, 123.4, 121.5, 119.0 (6d, 8 
arom. CH); 52.2 (q, MeO); 42.9 (t, CH2); 15.9 (q, MeCH2). CI-MS: 485 (100, [M+1]
+). Anal. 
calc. for C22H17ClN4O2Se (483.81): C 54.62, H 3.54, N 11.58; found: C 53.88, H 3.65, N 11.41. 
Methyl 4-[(4-Bromophenyl)amino]-1-ethyl-1H-5-selena-1,3,6-triazaaceanthrylene-2-carboxylate 
(9c). From 0.6 g (1.97 mmol) of 6 and 0.56 g (2.14 mmol) of 8c. Yield: 0.9 g (86.5%). Colorless 
crystals. M.p. 265 – 267° (MeOH), 266.8 – 267.0° (CH2Cl2/hexane). IR: 3274m, 3186m, 3099m, 
3050m, 2989m, 1694s, 1606s, 1586s, 1570s, 1546s, 1487s, 1461m, 1435m, 1395m, 1374m, 
1354w, 1309s, 1294s, 1264m, 1246m, 1223s, 1197m, 1181m, 1160m, 1135w, 1111m. 1H-NMR 
((D7)DMF): 10.40 (s, NH); 8.40 (d, J = 8.1, 1 arom. H); 8.21 (d, J = 8.5, 2 arom. H); 7.94 (d, J = 
8.1, 1 arom. H); 7.69 (t-like, 2 arom. H); 7.61 (d-like, 2 arom. H); 5.03 (q, J = 7.0, CH2); 4.11 (s, 
MeO); 1.60 (t, J = 7.0, MeCH2). 
13C-NMR ((D7)DMF): 162.7 (s, CO)
3); 153.1, 148.6, 148.5, 
140.9, 136.0, 131.2, 119.0, 117.6, 115.2, 105.8 (10s, 10 arom. C); 132.3, 129.9, 129.1, 126.5, 
                                                 
2) In all Se-containing products, the values for C were too low. 
3 ) Signal overlaps with the signal of DMF. 
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123.4, 121.9 (6d, 8 arom. CH); 52.2 (q, MeO); 42.9 (t, CH2); 15.9 (q, MeCH2). CI-MS: 529 (100, 
[M+1]+). Anal. calc. for C22H17BrN4O2Se (528.26): C 50.02, H 3.24, N 10.61; found C 49.33, H 
3.43, N 10.50. 
Methyl 1-Ethyl-4-[(4-methoxyphenyl)amino]-1H-5-selena-1,3,6-triazaaceanthrylene-2-
carboxylate (9d). From 0.4 g (1.31 mmol) of 6 and 0.36 g (1.69 mmol) of 8d. Yield: 0.5 g 
(79.4%). Yellowish crystals. M.p. 249.2 – 250.0° (CH2Cl2/hexane). IR: 3262w, 3198w, 3123w, 
3062m, 2988m, 2949m, 2833w, 1692s, 1601s, 1569s, 1535m, 1508s, 1476m, 1460m, 1438m, 
1414m, 1372m, 1354m, 1297m, 1279w, 1241s, 1218s, 1197m, 1179w, 1161m, 1136w, 1110m. 
1H-NMR (500 MHz, (D6)DMSO): 10.06 (s, NH); 8.30 (br. d, J = 8.0, 1 arom. H); 8.00 (br. d, J  = 
8.8, 2 arom. H); 7.89 (dd, J = 8.2, 1.2, 1 arom. H); 7.66 (td, J = 8.2, 1.2, 1 arom. H); 7.58 (td, J = 
8.2, 1.2, 1 arom. H); 6.94 (d-like, J = 9.1, 2 arom. H); 4.93 (q, J = 7.0, CH2); 3.97, 3.77 (2s, 2 
MeO); 1.50 (t, J = 7.0, MeCH2). 
13C-NMR ((D6)DMSO): 161.3 (s, CO); 154.9, 152.4, 147.1, 
135.6, 133.7, 131.0, 128.4, 115.9, 104.6 (9s, 10 arom. C); 128.5, 125.8, 122.5, 120.5, 117.7, 
113.7 (6d, 8 arom. CH); 55.2, 51.6 (2q, 2 MeO); 41.8 (t, CH2); 15.3 (q, MeCH2). CI-MS: 481 
(100, [M+1]+). Anal. calc. for C23H20N4O3Se (479.39): C 57.62, H 4.21, N 11.69; found C 55.90, 
H 4.22, N 11.32. 
Methyl 4-[(4-Chlorophenyl)(methyl)amino]-1-ethyl-1H-5-selena-1,3,6-triazaaceanthrylene-2-
carboxylate (10). To a soln. of 9b (0.2 g, 0.4 mmol) in dry pyridine (30 ml) was added a 
suspension of NaH in mineral oil (ca. 1.5 eq.) and 1.2 eq. CH3I. Usual workup and crystallization 
yielded 0.1 g (50%) of 10. Creamy-colored crystals. M.p. 215.1 – 215.5° (CH2Cl2/hexane). IR: 
3181w, 3048w, 2927m, 1695s, 1611m, 1596s, 1584s, 1567s, 1552s, 1489s, 1461s, 1435s, 1405m, 
1373s, 1350m, 1314s, 1285s, 1263m, 1243m, 1222s, 1191s, 1158m, 1127m, 1110s, 1090m. 1H-
NMR ((D7)DMF): 8.37 (d, J = 8.3, 1 arom. H); 8.35 (d-like, 1 arom. H); 7.88 (d-like, 2 arom. H); 
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7.85 – 7.49 (m, 4 arom. H); 5.00 (q, J = 6.8, CH2); 3.97 (s, MeO); 3.63 (s, MeN); 1.57 (t, J = 7.0, 
MeCH2). CI-MS: 499 (100, [M+1]
+). 
 
4. Preparation of Methyl 4-[(4-Bromophenyl)amino]-1-ethyl-1H-5-thia-1,3,6-triaza-
aceanthrylene-4-carboxylate (12). In analogy to the General Procedure (section 3), 12 was 
prepared from 0.4 g (1.32 mmol) of 6 and 0.29 g (1.35 mmol) of (4-bromophenyl) isothiocyanate. 
Yield: 0.4 g (63.5%). Pale yellow crystals. M.p. 286.1 – 286.5° (MeOH). IR: 3416w, 3305s, 
3194m, 3120m, 3054w, 2946w, 2926w, 2852w, 1662s, 1601s, 1562s, 1540s, 1487s, 1468s, 
1439m, 1395m, 1378m, 1353w, 1308s, 1293m, 1261m, 1249w, 1223s, 1199m, 1179m, 1157m, 
1132m, 1116m. 1H-NMR ((D7)DMF)
4): 12.93 (s, 0.33 NH); 10.43 (s, 0.66 NH); 8.61 – 8.59 (d-
like, 0.33 arom. H); 8.39 – 8.37 (d-like, 0.66 arom. H); 8.24 – 8.22 (m, 2 arom. H); 7.93 – 7.92 
(d-like, 0.33 arom. H); 7.89 – 7.88 (d-like, 0.66 arom. H); 7.70 – 7.53 (m, 4 arom. H); 5.04 (q, J = 
7, CH2); 4.09, 4.04 (2s, MeO); 1.59 (t, J = 7, MeCH2). 
13C-NMR ((D7)DMF)
4): 162.4, 162.0 (2s, 
CO); 153.0, 151.6, 151.1, 148.5, 148.0, 140.8, 135.1, 132.8, 132.6, 119.2, 119.1, 116.1, 115.3, 
107.1, 10.2 (15s, 10 arom. C); 132.3, 132.2, 129.9, 129.4, 129.2, 126.5, 126.2, 123.6, 123.4, 
122.3, 122.2 (11d, 8 arom. CH); 52.0, 51.9 (2q, MeO); 42.8 (t, CH2); 15.9 (q, MeCH2).
 CI-MS: 
483 (100, [M+1]+). Anal. calc. for C22H17BrN4O2S (481.36): C 54.89, H 3.56, N 11.64; found: C 
54.06, H 3.68, N 11.54. 
 
                                                 
4 ) Two tautomeric forms of 12 are present in a ratio of ca. 1 : 2. Some of the signals overlap. 
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5.  X-Ray Crystal-Structure Determination of 9c and 12 (Table and Figs. 1 and 2)5). All 
measurements were made on a Nonius KappaCCD diffractometer [25] using graphite-
monochromated MoKα radiation (λ 0.71073 Å) and an Oxford Cryosystems Cryostream 700 
cooler. The data collection and refinement parameters are given in the Table, and views of the 
molecules are shown in Figs. 1 and 2. Data reductions were performed with HKL Denzo and 
Scalepack [26]. The intensities were corrected for Lorentz and polarization effects, and, in the 
case of 9c, a numerical absorption correction [27] was applied, whereas in the case of 12, an 
absorption correction based on the multi-scan method [28] was applied. The structures were 
solved by direct methods using SIR92 [29], which revealed the positions of all non-H-atoms. 
In the case of 12, the asymmetric unit contains one molecule of 12 plus one molecule of 
DMSO. The non-H-atoms were refined anisotropically. In both structures, the NH-atom was 
placed in the position indicated by a difference electron density map and its position was 
allowed to refine together with an isotropic displacement parameter. All remaining H-atoms 
were placed in geometrically calculated positions and refined using a riding model where each 
H-atom was assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of 
its parent C-atom (1.5Ueq for the Me groups). Refinements of the structures were carried out 
on F2 using full-matrix least-squares procedures, which minimised the function Σw(Fo2 – 
Fc
2)2. A correction for secondary extinction was applied in both cases. Neutral atom scattering 
factors for non-H-atoms were taken from [30a], and the scattering factors for H-atoms were 
                                                 
5 ) CCDC-211324 & 211325 contain the supplementary crystallographic data for this paper. 
These data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from 
the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, U.K. (fax: 
+44-(0)1223-336033; e-mail: deposit@ccdc.cam.ac.uk).  
 
16 
taken from [31]. Anomalous dispersion effects were included in Fc [32]; the values for f ' and   
f " were those of [30b]. The values of the mass attenuation coefficients are those of [30c]. All 
calculations were performed using the SHELXL97 program [33]. 
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Legends 
 
Fig. 1. ORTEP-Plot [20] of the molecular structure of 9c (arbitrary numbering of atoms; 
50% probability ellipsoids) 
 
Fig. 2. ORTEP-Plot [20] of the molecular structure of 12 (arbitrary numbering of atoms; 
50% probability ellipsoids) 
 
